弥合免疫缺口:克服东南亚和南亚新疫苗引入的障碍
该研究通过广泛的叙述性综述比较了13个东南亚和南亚国家基于Gavi资助状态分组的新疫苗引入情况及关键因素。结果显示,符合Gavi中等收入国家支持条件的国家在引入肺炎球菌结合疫苗、人乳头瘤病毒疫苗和轮状病毒疫苗方面进展较慢,其国家免疫规划纳入的疫苗可预防疾病数(11.25 vs. 12)和世界卫生组织推荐疫苗数(8.3 vs. 9.2)均少于符合Gavi资格的同侪。主要障碍包括决策过程不完善、国内融资有限、疫苗价格高和免疫系统准备不足。
要点
- 符合Gavi MICs支持条件的国家新疫苗引入进展慢于Gavi资格国家。
- 主要障碍为决策不完善、融资有限、疫苗价格高及系统准备不足。
- 需加强治理与融资,优化资源并利用全球伙伴技术支持。
核心结论
- 符合Gavi中等收入国家支持条件的国家在新疫苗引入上落后,需加强治理、融资和伙伴支持以弥合缺口。
研究设计与样本
- 通过广泛的叙述性综述比较13个东南亚和南亚国家基于Gavi资助状态分组的新疫苗引入及相关因素。
主要发现
- 符合Gavi MICs支持条件的国家引入肺炎球菌结合疫苗、人乳头瘤病毒疫苗和轮状病毒疫苗进展较慢。
- 符合Gavi MICs支持条件的国家国家免疫规划纳入的疫苗可预防疾病数为11.25,少于Gavi资格国家的12。
- 符合Gavi MICs支持条件的国家国家免疫规划纳入的世界卫生组织推荐疫苗数为8.3,少于Gavi资格国家的9.2。
临床怎么用
- 各国应强化免疫规划治理和融资机制,优化资源使用以提升项目绩效。
- 利用全球伙伴的针对性技术支持加速新疫苗引入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many middle-income countries (MICs), particularly the ones ineligible for Gavi support, are falling behind in achieving Immunization Agenda 2030 targets. This study aims to compare the vaccine introduction status of national immunization programs across 13 Southeast and South Asian countries (Bangladesh, Cambodia, Lao PDR, Myanmar, India, Indonesia, Pakistan, Philippines, Viet Nam, Malaysia, Singapore, Sri Lanka, and Thailand) and identify key enablers and barriers associated with the new vaccine introduction. METHODS: Through an extensive narrative review of public data as well as published papers and reports, we compared the new vaccine introduction and associated key factors across three country groups based on their Gavi funding status. RESULTS: Countries eligible for Gavi's MICs support approach showed slower progress in introducing pneumococcal conjugate vaccine, human papillomavirus vaccine, and rotavirus vaccine, with fewer vaccine-preventable diseases (11.25 vs. 12) and vaccines recommended by the World Health Organization (8.3 vs. 9.2) included in their national immunization programs compared to Gavi-eligible peers. Major barriers include underdeveloped decision-making processes, limited domestic financing, high vaccine prices, and gaps in immunization system readiness. CONCLUSION: To accelerate progress, countries must strengthen governance and financing mechanisms, optimize resource use for a better-performed program, and leverage targeted technical support from global partners. Closing these gaps is essential to expanding equitable access to life-saving vaccines and safeguarding regional health security.
引用
- Zhang X, Chen S, Tang S, et al. Closing the immunization gap: Overcoming barriers for new vaccine introduction in Southeast and South Asia. Vaccine. 2025. PMID: 41406650. doi:10.1016/j.vaccine.2025.128119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。